verapamil has been researched along with luteolin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CH; Kim, JH; Kim, SH | 1 |
| Bucar, F; Gibbons, S; Lechner, D | 1 |
2 other study(ies) available for verapamil and luteolin
| Article | Year |
|---|---|
Reversal of P-glycoprotein-mediated MDR by 5,7,3',4',5'-pentamethoxyflavone and SAR.
Topics: Adenosine Triphosphatases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Enzyme Activation; Flavonoids; Humans; Leukemia, Myeloid, Acute; Structure-Activity Relationship; Vincristine | 2004 |
Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Enzyme Inhibitors; Ethidium; Genistein; Luteolin; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium smegmatis; Phenols; Resveratrol; Stilbenes; Verapamil | 2008 |